WEBULL
News
DGNOF
0.250
NaN%
--
Diagnos Inc. Appoints Dr. Ismail Ben Ayed as Chief AI Scientist
Reuters · 12/16 14:00
DIAGNOS ANNOUNCES CLOSING OF OVERSUBSCRIBED $4 MILLION BROKERED PRIVATE PLACEMENT LED BY CENTURION ONE CAPITAL
Reuters · 12/09 18:30
Diagnos Inc. Upsizes Private Placement to $3.65 Million
Reuters · 11/25 14:06
DIAGNOS ANNOUNCES UPSIZE OF PREVIOUSLY ANNOUNCED BROKERED PRIVATE PLACEMENT TO $3.65M LED BY CENTURION ONE CAPITAL
Reuters · 11/25 14:00
Diagnos Inc. Releases Q2 2026 MD&A Report
Reuters · 11/20 16:57
Diagnos Inc. posts Q2 revenue of $15,159 with net loss of $1.01 million
Reuters · 11/20 16:57
Diagnos Inc. Launches $2 Million Private Placement Led by Centurion One Capital
Reuters · 11/10 21:36
DIAGNOS ANNOUNCES $2.0 MILLION BROKERED PRIVATE PLACEMENT LED BY CENTURION ONE CAPITAL
Reuters · 11/10 21:36
DIAGNOS STRENGTHENS GOVERNANCE AND LEADERSHIP WITH THE APPOINTMENT OF PHILIPPE COUILLARD AS CHAIRMAN OF THE BOARD OF DIRECTORS
Reuters · 10/30 13:00
DIAGNOS WELCOMES DR. PIERRE-LUC CHARLEBOIS TO ITS ADVISORY BOARD
Reuters · 10/27 13:00
DIAGNOS to Extend Exercise Period of Stock Warrants Expiring on November 9, 2025
Barchart · 10/22 14:00
VALIDATED FOR GLOBAL SCALE: DIAGNOS PASSES ANNUAL MDSAP AUDIT, SOLIDIFYING THE PATHWAY TO APPROVALS WITH HEALTH CANADA & FDA
Reuters · 10/08 13:00
Diagnos Inc. Announced Results of Annual Shareholder Meeting
Reuters · 09/25 19:30
DIAGNOS Announces Voting Results of Meeting of Shareholders
Barchart · 09/25 14:30
Weekly Report: what happened at DGNOF last week (0908-0912)?
Weekly Report · 09/15 10:04
Weekly Report: what happened at DGNOF last week (0901-0905)?
Weekly Report · 09/08 10:05
Diagnos Inc. Closes $100,000 Private Placement to Fund AI-Based Product Development and Commercialization
Reuters · 09/05 19:45
DIAGNOS ANNOUNCES CLOSING OF PRIVATE PLACEMENT
Reuters · 09/05 19:45
Diagnos Inc. Announces $100,000 Private Placement to Fund AI-Based Health Screening Services
Reuters · 09/03 19:15
More
Webull provides a variety of real-time DGNOF stock news. You can receive the latest news about Diagnos Inc through multiple platforms. This information may help you make smarter investment decisions.
About DGNOF
Diagnos Inc. is a Canadian company, which is engaged in the early detection of critical eye-related health problems using advanced technology based on Artificial Intelligence (AI). It markets Computer Assisted Retinal Analysis (CARA), a software platform which assists health specialists in the detection of certain retinopathy pathologies through the computerized analysis of retina images. CARA is an in-house-hosted Web-based application that integrates fundus cameras with an image processing engine over a secure Internet connection. The CARA suite of applications allows an eye care specialist to more clearly visualize both normal retinal landmarks (optic nerve, vascular system, macula, fovea), and pathological changes (exudates, haemorrhages, micro-aneurisms, neo-vascularization). CARA is indicated for use by healthcare professionals in an adult general population in the context of a general eye-health exam.